It would be interestingly to see whether LINC00917 is also upregulated in NSCLC patients’ in situ tumor, which would provide further evidence to identify the origin of LINC00917 upregulation among NSCLC patients. This evidence concerns the gene LINC00917 and non-small cell lung carcinoma.